{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:20:39Z","timestamp":1790115639721,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005758","name":"Polytechnic University of Marche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005758","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ajp.2022.103121","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T02:16:22Z","timestamp":1649470582000},"page":"103121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A case report of clozapine-treatment-resistant schizophrenia successfully managed with brexpiprazole combination therapy"],"prefix":"10.1016","volume":"72","author":[{"given":"Laura","family":"Orsolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bellagamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginio","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2\u20133","key":"10.1016\/j.ajp.2022.103121_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0920-9964(95)00070-4","article-title":"A psychometric comparison of the Calgary depression scale for schizophrenia and the hamilton depression rating scale","volume":"19","author":"Addington","year":"1996","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.ajp.2022.103121_bib2","article-title":"Alcohol use disorder and schizophrenia or schizoaffective disorder","volume":"40","author":"Archibald","year":"2019","journal-title":"Alcohol Res."},{"key":"10.1016\/j.ajp.2022.103121_bib3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.ajp.2022.103121_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5498\/wjp.v11.i8.429","article-title":"Clozapine resistant schizophrenia: newer avenues of management","volume":"11","author":"Chakrabarti","year":"2021","journal-title":"World J. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2022.103121_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/1381612826666200110102254","article-title":"Augmentation strategies for clozapine-resistant patients with schizophrenia","volume":"26","author":"Chiu","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.ajp.2022.103121_bib6","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.MY20096AH1C","article-title":"Treatment-resistant schizophrenia: definition, predictors, and therapy options","volume":"82","author":"Correll","year":"2021","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2022.103121_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1176\/jnp.2008.20.1.117","article-title":"Aripiprazole diminishes cannabis use in schizophrenia","volume":"20","author":"Desseilles","year":"2008","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.ajp.2022.103121_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.64719\/pb.4399","article-title":"Brexpiprazole for the treatment of schizophrenia and major depressive disorder: a comprehensive review of pharmacological considerations in clinical practice","volume":"51","author":"Edinoff","year":"2021","journal-title":"Psychopharmacol. Bull."},{"issue":"6","key":"10.1016\/j.ajp.2022.103121_bib9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/JCP.0000000000000794","article-title":"Effective switch from clozapine to aripiprazole in treatment-resistant schizophrenia and comorbid alcohol use disorder","volume":"37","author":"Feeley","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.ajp.2022.103121_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00006199-198909000-00006","article-title":"Visual analogue scales: measurement of subjective phenomena","volume":"38","author":"Gift","year":"1989","journal-title":"Nurs. Res."},{"key":"10.1016\/j.ajp.2022.103121_bib11","series-title":"ECDEU Assessment Manual for Psychopharmacology: Revised (DHEW publication number ADM 76-338)","first-page":"534","author":"Guy","year":"1976"},{"key":"10.1016\/j.ajp.2022.103121_bib12","series-title":"Task Force for the Handbook of Psychiatric Measures (eds.). Handbook of Psychiatric Measures","article-title":"Clinical global impressions (CGI) scale, modified","author":"Guy","year":"2000"},{"key":"10.1016\/j.ajp.2022.103121_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med Psychol."},{"issue":"1","key":"10.1016\/j.ajp.2022.103121_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1039856217732473","article-title":"Brexpiprazole: a new leaf on the partial dopamine agonist branch","volume":"26","author":"Hope","year":"2018","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103121_bib15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.drugalcdep.2018.07.011","article-title":"Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: systematic review and meta-analysis","volume":"191","author":"Hunt","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.ajp.2022.103121_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2022.103121_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/bs.apha.2017.09.009","article-title":"Unique effects of clozapine: a pharmacological perspective","volume":"82","author":"Khokhar","year":"2018","journal-title":"Adv. Pharmacol."},{"issue":"2","key":"10.1016\/j.ajp.2022.103121_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s40199-019-00282-3","article-title":"Treatment of amphetamine abuse\/use disorder: a systematic review of a recent health concern","volume":"27","author":"Khoramizadeh","year":"2019","journal-title":"Daru"},{"key":"10.1016\/j.ajp.2022.103121_bib19","article-title":"Brexpiprazole in the treatment of cannabis withdrawal psychotic disorder","author":"Kung","year":"2021","journal-title":"Am. J. Ther."},{"issue":"2","key":"10.1016\/j.ajp.2022.103121_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.wnf.0000240947.51994.96","article-title":"Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review","volume":"30","author":"Lerma-Carrillo","year":"2007","journal-title":"Clin. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.ajp.2022.103121_bib21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/13543784.2016.1175431","article-title":"Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives","volume":"25","author":"Martinotti","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"4","key":"10.1016\/j.ajp.2022.103121_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0364-7722(79)90058-4","article-title":"Depressive symptoms in acute schizophrenia","volume":"3","author":"Montgomery","year":"1979","journal-title":"Prog. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.ajp.2022.103121_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/FBP.0000000000000268","article-title":"Aripiprazole for cocaine abstinence: a randomized-controlled trial with ecological momentary assessment","volume":"28","author":"Moran","year":"2017","journal-title":"Behav. Pharm."},{"issue":"3","key":"10.1016\/j.ajp.2022.103121_bib24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"3","key":"10.1016\/j.ajp.2022.103121_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.euroneuro.2011.08.005","article-title":"Clozapine resistance: augmentation strategies","volume":"22","author":"Porcelli","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.ajp.2022.103121_bib26","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/14740338.2016.1191468","article-title":"Clozapine\u2019s critical role in treatment resistant schizophrenia: ensuring both safety and use","volume":"15","author":"Remington","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"issue":"3","key":"10.1016\/j.ajp.2022.103121_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/WNF.0b013e3182908330","article-title":"Aripiprazole for treating cannabis-induced psychotic symptoms in ultra high-risk individuals","volume":"36","author":"Rolland","year":"2013","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ajp.2022.103121_bib28","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.2147\/DDDT.S240859","article-title":"Brexpiprazole for the treatment of schizophrenia in adults: an overview of its clinical efficacy and safety and a psychiatrist\u2019s perspective","volume":"14","author":"Watanabe","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"issue":"Suppl 3","key":"10.1016\/j.ajp.2022.103121_bib29","first-page":"574","article-title":"Clozapine: promising treatment for suicidality in bipolar disorder","volume":"31","author":"Wilkowska","year":"2019","journal-title":"Psychiatry Danub."},{"key":"10.1016\/j.ajp.2022.103121_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201822001198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201822001198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:44:48Z","timestamp":1761756288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201822001198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":30,"alternative-id":["S1876201822001198"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2022.103121","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case report of clozapine-treatment-resistant schizophrenia successfully managed with brexpiprazole combination therapy","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2022.103121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103121"}}